Status | Study |
Recruiting |
Study Name: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases Condition: Age-Related Macular Degeneration Polypoidal Choroidal Vasculopathy Date: 2017-03-09 Interventions: Drug: Intravitreal injection of conbercept We observe and collect patients with macular neovascular dise |
Recruiting |
Study Name: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2016-08-21 Interventions: Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Recruiting |
Study Name: Ocular Discomfort Assessment After Intravitreal Injections Condition: Macular Degeneration Diabetic Retinopathy Retinal Artery O Date: 2016-06-14 Interventions: Drug: Optive Optive eye drops will be prescribed to each included patients after their second intravitre |
Completed |
Study Name: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. Condition: Choroidal Neovascularization Secondary to Pathologic Myopia Date: 2014-01-09 Interventions: Drug: Ranibizumab All patients will receive a single initial intravitreal injection of ranibizumab 0.5 m |
Recruiting |
Study Name: Efficacy Study of Different Lens Treatments on Chinese Adolescent Myopia Condition: Progressive Myopia Date: 2013-11-23 Interventions: Other: Spectacles Normal spect |
Completed |
Study Name: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia Condition: Myopia, Degenerative Date: 2013-07-10 Interventions: Drug: PDT standard fluence, ranibizumab |
Completed |
Study Name: A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV Condition: Choroid Neovascularization Secondary to Degenerative Myopia Date: 2013-03-11 Interventions: Drug: conbercept, Fixed intrav |
Completed |
Study Name: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia Condition: Choroidal Neovascularization Myopia, Degenerative Date: 2011-08-22 Interventions: Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- |
Completed |
Study Name: VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV) Condition: Myopia, Pathological Date: 2010-11-26 Interventions: Biological: VEGF Trap-Eye (BAY86-5321) |
Completed |
Study Name: Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia Condition: Pathological Myopia Date: 2010-10-06 Interventions: Drug: Ranibizumab 0.5 mg ranib |